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A specific interaction between purified liver transglutaminase and small unilamellar phospholipid vesicles 
at the lipid phase transition have been revealed. The enzyme-induced perturbation of the bilayer is 
sufficient for phase transition release of encapsulated carboxyfluorescein from the vesicles. The size of the 
enzyme-phospholipid recombinants depends upon the protein-phospholipid ratio as shown on Sepharose 
4B elution profile. The activity of transglutaminase inserted into the bilayer is greatly reduced. The 
interaction does not occur when the phospholipid vesicle are in the solid or liquid phase and it requires 
the structural integrity of the enzyme. 
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1. INTRODUCTION 
Transglutaminases catalyze an acyl-transfer 
reaction, with the concomitant release of am- 
monia, between peptide-bound glutamine and a 
series of primary amines including the e-amino 
group of lysine in appropriate proteins [l]. In the 
latter case an l -(y-glutaminyl)lysine bond is form- 
ed, which is a unique example of enzyme-catalyzed 
intermolecular cross-link formation. The in- 
tracellular/tissue form of the enzyme has been 
localized in the nucleus [2], cytosol and membrane 
fraction [3] of mammalian cells and its role im- 
plicated in such important cellular phenomena like 
receptor-mediated endocytosis [4], ageing [5], in- 
itiation of cell proliferation [6] and surface-related 
immunological reactions [7]. However, little is 
known about the intracellular regulation of trans- 
glutaminase. It is a Ca’+-dependent enzyme which 
needs at least 0.1-l .O mM Ca*+ for showing 
catalytic activity [S]. On the other hand, we could 
not demonstrate an activation mechanism with 
calmodulin in purified system [9]. Some recent 
results [16,10] suggest the regulation of intra- 
cellular transglutaminase activity mainly through 
de novo synthesis-degradation mechanisms, 
though its translocation within the cell accom- 
panied by abrupt changes of activity has been also 
demonstrated [2,1 I]. Here we report that an in- 
teraction takes place between transglutaminase 
and phospholipid vesicles, when the latter is in the 
crystalline-liquid transition state and the interac- 
tion results in a modulation of transglutaminase 
activity. 
2. MATERIALS AND METHODS 
2.1. Phospholipids, proteins and other chemicals 
Dipalmitoylphosphatidylcholine (DPPC), dilau- 
roylphosphatidylcholine (DLPC), dimyristoyl- 
phosphatidylcholine (DMPC), distearylphosphati- 
dylcholine (DSPC), dipalmitoylphosphatidyletha- 
nolamine (DPPE), dipalmitoylphosphatidylserine 
(DPPS), liver phosphatidylcholine (PC), lysophos- 
phatidylcholine (LyPC), phosphatidylethanol- 
amine (PE), lysophosphatidylethanolamine 
(LyPE) and brain phosphatidylinositol (PI) were 
obtained from Sigma. Samples of 1OOpg gave 
single spots on thin-layer chromatograms. Agarose 
was purchased from Bio-Rad; z-l-glutaminyl-gly- 
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tine from Vega Chemicals; carboxyfluorescein 
from Kodak; HSA, glutamate dehydrogenase and 
metilamine from Sigma. Actin was purified from 
bovine platelets [12]. All other used reagents were 
of reagent grade. 
2.2. Preparation of phospholipid vesicles 
Phospholipids were dissolved in 
chloroform-methanol (2 : l), thin-filmed under 
nitrogen, hydrated (0.1 M NaCI, 0.025 M 
Tris-HCl, pH 7.5) by vortex mixing, then 
sonicated (Branson type B30 Sonicator power level 
4) under nitrogen for 1 h at 1°C above the transi- 
tion state temperature (Tc) of the particular 
phospholipid. The vesicles were centrifuged at 
100 x g for 5 min and unilamellar vesicles were ob- 
tained either by fractionation in a 1.6 x 25 cm 
Sepharose 4B column [13] or by differential high- 
speed ultracentrifugation [ 141. The small 
unilamellar vesicles fractions did not contain 
degradation products checked by thin-layer 
chromatography or autooxidation products detec- 
table by absorbance measurement at 233 nm [ 151. 
The phospholipid content was determined using 
the method in [16]. 
release (PTR) technique [17] it has been success- 
fully used to demonstrate specific interactions at 
the lipid phase transition temperature (Tc) between 
lipid bilayers and proteins like tubulin [17], actin 
[21] and lipoproteins [ 181. Tissue transglutaminase 
can also induce a smooth, rapid release of water- 
soluble carboxyfluorescein (the encapsulated ye is 
quenched inside the vesicles but gives fluorescence 
when released and diluted into the external 
medium) from small unilamellar DPPC vesicles 
during scans through Tc (fig.1). The PTR is 
enzyme concentration-dependent (fig.2). The 
lipid/protein molar ratio sufficient for 50% 
protein-induced release is about 250: 1 using M,‘s 
of 80 000 for TGase [l] and 733 for DPPC in the 
calculation. At this ratio, recycling of the en- 
zyme-lipid complex through Tc does not induce 
further release of carboxyfluoresceine (not 
shown); i.e., the interaction is all or none and ir- 
reversible [18]. The vesicles show the same 
response to actin as in [21] and do not respond to 
HSA. Heat-inactivated TGase can not induce 
PTR; i.e., a structural integrity possessed by the 
intact enzyme molecule is essential for the interac- 
tion. Cazf-induced conformational change of 
TGase (which is needed for the catalytic activity) is 
2.3. Phase transition release (PTR) 
DPPC small unilamellar vesicles containing car- 
boxyfluorescein (CF) were prepared as in [17] for 
the measurements of phase transition release. 
Changes in fluorescence intensity following the 
release of CF from the vesicles were measured us- 
ing a Hitachi Perkin Elmer MPR fluorometer at 
5 15 nm using exciting wavelength at 470 nm as 
described in [18]. 
2.4. Transglutaminase 
Purified guineapig liver transglutaminase was 
prepared as in [ 191. It was electrophoretically pure 
and had a spec. act. of 12.5 units/mg as determin- 
ed by an assay in which the ammonia released ur- 
ing the transfer reaction between z-l-glutaminyl- 
glycine and methylamine was measured as describ- 
ed in [20]. One unit of the enzyme was defined as 
the amount catalyzing the release of 1 rmol 
NH3/min at 37°C. 
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3. RESULTS AND DISCUSSION 
Since the introduction of the phase transition 
2 
F&l. Phase transition release (PTR) profile of small 
unilamellar DPPC vesicles (SOpM) obtained in the 
presence or absence (control) of TGase (SOpg/ml). 
Vesicles and the enzyme were mixed at room 
temperature and the PTR curve was obtained as in [ 171; 
(0) temperature in the cuvette. 
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Fig.2. Dependence of phase transition release (PTR) 
from small unilamellar DPPC vesicles on TGase 
concentration. Various concentrations of intact or 
inactive (heat denatured for 30 min at 60°C) TGase, 
platelet actin and HSA were added to the vesicles; then 
PTR curves were obtained. The vesicle/lipid 
concentration was 50pM. Per cent release of carboxy- 
fluorescein was calculated after complete release by 
Triton X-100. 
not a prerequisite. Besides, neither does it reduce 
the PTR-inducing capacity (not shown). 
The PTR experiments uggest hat TGase can be 
integrated into the lipid membrane at phase transi- 
tion of the latter to form stable enzyme-vesicle 
recombinants. The Sepharose 4B elution profiles 
shown in fig.3 reveal some of the molecular details 
of the TGase-induced bilayer perturbation . There 
is no interaction (Panel A) when the enzyme is mix- 
ed with solid phase vesicles (T, of DPPC is 38°C 
[IS]) and the enzyme activity is unchanged. Fluid 
phase vesicles, in our case DLPC which have a T, 
at - 1.8”C [21], do not bind significant amounts 
of TGase either (Panel B), and TGase activity is 
not influenced. When the enzyme is present during 
phase transition, the consequence of the perturba- 
tion depends upon the lipid/protein ratio. When it 
is about 100 : 1 (Panel C) the result is the formation 
of vesicle-protein recombinants eluting in the void 
volume and significantly reduced TGase activity. 
In addition, there is a phospholipid peak represen- 
ting intact vesicles and a protein one without 
catalytic activity (most probably the portion of 
denatured TGase inert in our preparation). When 
the lipid/protein ratio is about 25: 1 the elution 
profile (Panel D) shows that the small vesicles 
disappeared, most of the phospholipid material is 
associated with the enzyme fraction in which the 
catalytic activity is reduced. Large vesicle-enzyme 
m 12 
1 m I 
lm 6 
I 
50 3 
ul 50 
FRETON NUMBER 
Fig.3. Sepharose 4B profile of the mixture made from 
small unilamellar phosphatidylcholine vesicles and 
TGase. Panel A, DPPC (1.2 mg/ml) vesicles and TGase 
(1.2 mg/ml) mixed at room temperature; Panel B, 
DLPC (1.2 mg/ml) vesicles and TGase (1.2 pg/ml) 
mixed at room temperature; Panel C, DPPC 
(1.2 mg/ml) vesicles and TGase (300 pg/ml) mixed at 
room temperature then warmed up to 43°C before 
chromatography; Panel D, DPPC (1.2 mg/ml) vesicles 
and TGase (1.2 mg/ml) mixed at room temperature then 
warmed up to 43°C before chromatography. The 
vesicles were prepared as in [13]. Chromatography was 
performed at room temperature collecting l.O-ml 
fractions from which phospholipid (0) and protein (x- 
determined by Bio-Rad Protein Assay) concentrations as 
well as TGase activity (closed bars) was measured. 
Column size: 1.6 x 30 cm; references: (1) blue dextran; 
(2) large unilamellar vesicles prepared as in [13]; (3) 
HSA. 
recombinants could be also seen. Therefore, lower 
lipid/protein ratios (at least lower then 25: 1) 
favour disruption of vesicles at phase transition. 
High ratios (at least higher than 100: 1) favour the 
formation of large recombinants (fusion?; vesicle 
aggregation?; increased size with the protein?) ac- 
companied by the association of TGase with them. 
It is known, that the perturbation/disruption of 
3 
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the lipid bilayer can be induced by phospholipases. 
Since we could not find phospholipid breakdown 
products by thin-layer chromatography or detect 
phospholipase activity in any of the fractions or 
TGase preparations, this possibility was ruled out. 
Studying the effect of the interaction between 
TGase and phospholipid vesicles of various kinds 
on the enzyme activity a pattern consistent with the 
above findings has been revealed (fig.4 and 5). 
Those vesicles which have a Tc above 37°C or 
below O”C, that is DPPC, DSPC, DPPE, DPPS 
and DLPC [22], do not influence TGase activity. 
Vesicles made from PC, LyPC, PE, LyPE of liver 
origin or DMPC, which have a phase transition 
[22] in the temperature range of 0-37°C passed by 
the enzyme during the procedure of activity 
measurement, inhibit the enzyme in a concentra- 
tion-dependent manner. Charged or uncharged, 
natural or synthetic as well as lysophospholipids 
were equally effective, provided the Tc criterion 
was met. Consequently, the main requirement for 
I,. 4 
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Fig.4. The effect of interaction of TGase with 
phosphatidylcholine vesicles on its catalytic activity. 
20pg TGase was added at 0°C to small unilamellar 
vesicles prepared from various phosphatidylcholines as 
described in [14]. The mixture was incubated at 37°C for 
5 min, then added to the assay constituents at 37°C to 
measure catalytic activity. Original activity means the 
result was obtained with buffer instead of vesicles. 
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Fig.5. The effect of interaction of TGase with phospha- 
tidylcholine vesicles on its activity. Small unilamellar 
vesicles prepared as in [ 141 were mixed to 20 pg TGase 
at 0°C then warmed up to 37°C for 5 min. TGase 
activity was measured adding the enzyme-phospholipid 
mixture to assay constituents. 
the inhibition appears to be the hydrophobic en- 
vironment provided by the phospholipid hydrocar- 
bon chain whenever the enzyme is inserted into the 
bilayer. The inhibition is never complete and 
usually reaches its maximum at phospholipid/pro- 
tein ratios 10-20: 1. At this ratio complete PTR 
and the formation of TGase-phospholipid recom- 
binants can be induced (see above). 
There are several data which indicate that the 
demonstrated interaction of TGase with 
phospholipid bilayer may have cellular 
significance; e.g., the translocation of the enzyme 
[2,11], and the abrupt change of its activity 
[2,7,10] in various cell conditions, the presence of 
a significant amount of inhibited enzymes in cells 
[lo]. The in vivo formation of TGase-phospho- 
lipid recombinants may be responsible for the 
demonstrated presence of more than one form of 
the enzyme in a cell [23,24], especially the ones 
which differ only slightly in electrophoretic mobili- 
ty [25]. In addition, one can not exclude the 
possibility that some of the reported differences of 
enzyme activity in various cells or in a cell type 
4 
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under various conditions [2,5-7,111 are merely the 
consequences of the in vitro homogenizing pro- 
cedures inducing TGase-lipid interactions to 
various degrees. Obviously, further studies are 
needed to clarify the cellular significance of the 
results reported here, especially in relation to the 
implication of TGase in the mentioned cellular 
phenomena [3-7,261. Such experiments are in pro- 
gress in our laboratory. 
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